Key result
This review highlights the challenges of diagnosing and managing stress-induced cardiomyopathy during the COVID-19 pandemic, recommending point-of-care ultrasound to minimize physician-patient contact.
Why the study?
Diagnosis of takotsubo syndrome during acute COVID-19 infection is challenging because conventional imaging modalities should be restricted to minimize contact, requiring physicians to understand special diagnostic and management considerations.
Provides guidance on the diagnosis and management of stress-induced cardiomyopathy during the COVID-19 pandemic, emphasizing the use of point-of-care ultrasound to minimize exposure.
Answers are grounded in this paper and cite their sources.
May guide reduced-contact diagnostics in stress cardiomyopathy amid pandemics; leaves open prospective validation.
The novel coronavirus disease 2019 (COVID-19) is associated with several cardiovascular manifestations including myocardial injury, myocarditis, arrhythmia, and pulmonary embolism. Rare cases of stress-induced cardiomyopathy, or takotsubo syndrome have also been reported during the acute infection, and secondary to stress following lockdown and self-isolation. Diagnosis in the setting of the acute infection is challenging since conventional imaging modalities such as transthoracic echocardiography and coronary angiography should be restricted to minimize physician-patient contact until the patients is tested negative for COVID-19. The use of point of care hand-held ultrasound is appropriate for this purpose. The overall course of the disease seems to be similar to takotsubo in the general population. Physicians should be familiar with the clinical presentation, possible complications, and management of takotsubo during COVID-19 outbreak. Here, we review the special considerations in the diagnosis and management of takotsubo syndrome during the current pandemic.
No takes yet. Share an insight, caveat, or question.
Moady et al. (2022) conducted a review in Stress-induced cardiomyopathy (takotsubo syndrome) and COVID-19. Diagnosis and management strategies was evaluated. This review highlights the challenges of diagnosing and managing stress-induced cardiomyopathy during the COVID-19 pandemic, recommending point-of-care ultrasound to minimize physician-patient contact.
Synapse has enriched 10 related papers. Consider them for comparative context: